Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Venkat Reddy Mekala
Observed names:
V Mekala,
V.R. Mekala,
Venkat Mekala,
Venkat R. Mekala
Institution:
Suven Life Sciences (India)
Observed institution:
Suven Life Sciences (India)
OpenAlex ID:
A5059610421
SUVN-502, a novel, potent, pure, and orally active 5-HT6 receptor antagonist: pharmacological, behavioral, and neurochemical characterization
2018
·
Ramakrishna Nirogi
, Renny Abraham
, et al.
·
Behavioural Pharmacology
·
39
Discovery and Development of 3-(6-Chloropyridine-3-yloxymethyl)-2-azabicyclo[3.1.0]hexane Hydrochloride (SUVN-911): A Novel, Potent, Selective, and Orally Active Neuronal Nicotinic Acetylcholine α4β2 Receptor Antagonist for the Treatment of Depression
2020
·
Ramakrishna Nirogi
, Abdul Rasheed Mohammed
, et al.
·
Journal of Medicinal Chemistry
·
32
Discovery and Preclinical Characterization of Usmarapride (SUVN-D4010): A Potent, Selective 5-HT4 Receptor Partial Agonist for the Treatment of Cognitive Deficits Associated with Alzheimer’s Disease
2021
·
Ramakrishna Nirogi
, Abdul Rasheed Mohammed
, et al.
·
Journal of Medicinal Chemistry
·
19
Samelisant (SUVN-G3031), a potent, selective and orally active histamine H3 receptor inverse agonist for the potential treatment of narcolepsy: pharmacological and neurochemical characterisation
2021
·
Ramakrishna Nirogi
, Vijay Benade
, et al.
·
Psychopharmacology
·
16
P1‐310: Suvn‐g3031, an h3 receptor inverse agonist, produces procognitive effects without affecting sleep in preclinical models
2015
·
Vijay S. Benade
, Saivishal Daripelli
, et al.
·
Alzheimer s & Dementia
·
4
0120 SUVN-G3031, a Novel, Potent and Selective Histamine H3 Receptor Inverse Agonist for the Treatment of Narcolepsy: Preclinical Characterization
2019
·
Gopinadh Bhayrapuneni
, Venkatesh Kamuju
, et al.
·
SLEEP
·
3
P1‐397: Suvn‐g3031: a Novel and Potent Histamine H3 Receptor Antagonist for Potential Treatment of Cognitive Deficits
2014
·
Medapati Rajesh Babu
, Nageswararao Muddana
, et al.
·
Alzheimer s & Dementia
·
3
PDF
SUVN‐I6107: A novel muscarinic M1 receptor‐positive allosteric modulator (M1‐PAM) for the treatment of cognitive deficits
2020
·
Renny Abraham
, Venkatesh Goura
, et al.
·
Alzheimer s & Dementia
·
1
PDF
P4‐257: SUVN‐G1031, a novel selective H3 receptor antagonist in animal models of cognitive deficits
2011
·
Pradeep Jayarajan
, Dhanalakshmi Shanmuganathan
, et al.
·
Alzheimer s & Dementia
·
1
Samelisant (SUVN-G3031), a Histamine H3 Receptor Inverse Agonist in Animal Models of Sleep Disorders
2022
·
V. Benade
, R. Abraham
, et al.
·
Sleep Medicine
0265 Samelisant (SUVN-G3031), a Histamine H3 Receptor Inverse Agonist in Animal Models of Narcolepsy
2022
·
Vijay Benade
, Renny Abraham
, et al.
·
SLEEP
PDF
005 Samelisant (SUVN-G3031), a histamine H3 receptor inverse agonist in animal models of sleep disorders
2021
·
Saivishal Daripelli
, Parusharamulu Molgara
, et al.
·
SLEEP
0072 Preclinical Characterization of SUVN-G3031, a Histamine H3 Receptor Inverse Agonist for the Treatment of Narcolepsy
2020
·
P Jayarajan
, R Subramanian
, et al.
·
SLEEP
SUVN-G3031, A histamine H3 receptor inverse agonist for the treatment of narcolepsy with or without cataplexy: a preclinical characterization
2019
·
G. Bhayrapuneni
, V. Kamuju
, et al.
·
Sleep Medicine
P3‐193: Suvn‐502: In‐vitro Pharmacological Profile of a Pure 5‐ht6 Receptor Antagonist
2019
·
Ramkumar Subramanian
, Venkat Reddy Mekala
, et al.
·
Alzheimer s & Dementia
PDF
P1‐077: In‐vitro Characterization of Suvn‐i2004: a Novel Muscarinic M1 Positive Allosteric Modulator
2018
·
Ramkumar Subramanian
, Venkat Reddy Mekala
, et al.
·
Alzheimer s & Dementia
P3‐455: Suvn‐m8036, a Serotonergic and Dopaminergic Modulator, Alleviates Psychosis and Depression
2018
·
Arun Babu Vuyyuru
, Rajesh Kallepalli
, et al.
·
Alzheimer s & Dementia
P3‐135: SUVN‐I4035 ‐ Preclinical Characterization of Novel Muscarinic M1 Positive Allosteric Modulator
2016
·
Renny Abraham
, Anil K. Shinde
, et al.
·
Alzheimer s & Dementia
P4‐235: Pro‐cognitive properties of SUVN‐G1010034, a potent selective H3 antagonist in animal models of cognition
2012
·
Ramakrishna Nirogi
, Vishwottam Kandikere
, et al.
·
Alzheimer s & Dementia
IC‐P‐107: SUVN‐90716: A Selective 5‐HT6 Antagonist for the Potential Treatment of Alzheimer's Disease
2010
·
Ramakrishna Nirogi
, Vishwottam Kandikere
, et al.
·
Alzheimer s & Dementia
Show more works
View as search
Works count:
20
Citation count:
118
H-index:
4
I10-index:
4
Year
Topic
Type